Notice of Resolutions Adopted at the 2025 Annual General Meeting of Shareholders of Hunan Zhengqing Pharmaceutical Group Co., Ltd.
Category:
Release time:
2026-06-23
Hunan Zhengqing Pharmaceutical Group Co., Ltd.
Announcement of Resolutions Adopted at the 2025 Annual General Meeting of Shareholders
I. Convening and Attendance of the Meeting
Date and Time of the Meeting: 9:30 a.m., June 23, 2026
Meeting Location: Conference Room on the 5th Floor, No. 7 Caifu Road, Huaihua High-Tech Development Zone, Hunan Province
Method of convening: In-person
Meeting Convenor: Board of Directors
Meeting Chair: Chairman Wu Feichi
The shareholders and shareholder representatives attending this shareholders’ meeting totaled 17 Position, holding voting rights 170,488,448 shares, representing of the company’s total voting shares 85.77%。
- Status of the Deliberation on the Proposal
This meeting reviewed a total of eight proposals, as follows:
1. “2025 Annual Report of the Board of Directors”;
2. “The Company’s 2025 Annual Report of the Supervisory Board”;
3. Proposal on the Company’s 2025 Annual Financial Accounting Report;
4. “Company’s 2025 Annual Financial Closing and 2026 Financial Budget Report”;
5. “2025 Annual Profit Distribution Plan of the Company”;
6. Proposal on the Appointment of the Auditor for the Year 2026;
7. Proposal on Confirming the Company’s Routine Related-Party Transactions for 2025 and Projecting Such Transactions for 2026 (This proposal is related to the shareholders concerned.) (All have recused themselves from the vote) ;
8. “Proposal on the Election of Xiang Weiguo as a Supervisor of the Company.”
Voting Results: All eight proposals considered at this meeting were approved.
III. Details of the Lawyer’s Witnessing
This shareholders’ meeting was witnessed and accompanied by legal opinions from Attorneys Liu Zhongming and Xia Peng of Hunan Qiyuan Law Firm, who concluded that the convening and conduct of the meeting, the qualifications of the attendees, the voting procedures, and the voting results were all lawful and valid.
Hunan Zhengqing Pharmaceutical Group Co., Ltd.
June 23, 2026